EC Healthcare
EC Healthcare provides personal and household services, primarily operating in the consumer non-cyclical sector.
Business. EC Healthcare (2138.HK) is a personal services company listed on the Hong Kong Stock Exchange. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on the Personal & Household Products & Services industry. As specific operating segment and geographic data are not provided, the company is described at the industry level. Its primary business activity involves providing personal services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
EC Healthcare (2138.HK) is a personal services company listed on the Hong Kong Stock Exchange. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on the Personal & Household Products & Services industry. As specific operating segment and geographic data are not provided, the company is described at the industry level. Its primary business activity involves providing personal services.
EC Healthcare's capital structure is characterized by a lack of dilution risk, as the number of basic and diluted shares outstanding is identical at 1,185,211,265 shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability metrics are not available for EC Healthcare, and no industry-specific preferred metrics have been provided for comparison. The company reported a negative EPS of -0.02 HKD in the latest period, indicating a loss per share.
Segment and geographic exposure details are not disclosed in the available data, making it difficult to assess revenue concentration or geographic diversification.
The company's growth trajectory is unclear, as no outlook data or revenue history is provided beyond the latest actual revenue of 4,211,034,000 HKD.
Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. Dilution risk is currently low, as no dilution potential is indicated in the data.
Recent events or filings are not disclosed in the available data, and no transcripts or other public disclosures are referenced.
- EC Healthcare operates in the Personal Services industry with a classification confidence of 0.92.
- The company reported a negative EPS of -0.02 HKD in the latest period.
- No liquidity risk assessment is available due to missing balance-sheet data.
- Dilution risk is currently low, with no dilution potential identified.
- Revenue concentration and geographic exposure details are not disclosed.
- Growth trajectory and future outlook are unclear due to limited data availability.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue HK$4.14B, −1,7% YoY; Operating income −25,4% YoY.
- ▍Revenue HK$4.14B, −1,7% YoY
- ▍Operating income −25,4% YoY
- ▍Net income −782,4% YoY
- ▍Free cash flow +6,1% YoY
- ▍Net margin -4.0%
Revenue HK$4.21B, +8,7% YoY; Operating income −40,1% YoY.
- ▍Revenue HK$4.21B, +8,7% YoY
- ▍Operating income −40,1% YoY
- ▍Net income −127,2% YoY
- ▍Free cash flow +159,9% YoY
- ▍Net margin -0.4%
Revenue HK$3.88B, +32,7% YoY; Operating income −49,5% YoY.
- ▍Revenue HK$3.88B, +32,7% YoY
- ▍Operating income −49,5% YoY
- ▍Net income −64,7% YoY
- ▍Free cash flow −4,3% YoY
- ▍Net margin 1.8%
Revenue HK$2.92B, +40,3% YoY; Operating income +30,4% YoY.
- ▍Revenue HK$2.92B, +40,3% YoY
- ▍Operating income +30,4% YoY
- ▍Net income +2,4% YoY
- ▍Free cash flow −37,4% YoY
- ▍Net margin 6.8%
Revenue HK$2.08B; Operating income HK$284.6M.
- ▍Revenue HK$2.08B
- ▍Operating income HK$284.6M
- ▍Net margin 9.3%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- EC Healthcare Market data — financials · 2026-05-26
- EC Healthcare Market data — analyst estimates · 2026-05-26
Ownership & reference
Leadership
- Chi Fai TangExecutive Chairman of the Board
- Leslie LuChief Executive Officer, Executive Director